EHCNYSEServices-HospitalsUS GAAP · USD

Encompass Health Corp

Encompass Health Corp owns and operates inpatient rehabilitation hospitals that treat patients recovering from major injury or illness and needing intensive therapy to regain function and independence. It is the largest U.S. operator in this niche by patients treated, revenue, and hospital count, with a network spanning 39 states and Puerto Rico.

Liikevaihto5 935milj. USD
+10,5 %v/v
Nettotulos566milj. USD
+24,2 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

02 0004 0006 000milj. USD2020: 4 644 milj. USD2020: EBIT 564 milj. USD20202021: 4 015 milj. USD2021: EBIT 560 milj. USD20212022: 4 349 milj. USD2022: EBIT 540 milj. USD20222023: 4 801 milj. USD20232024: 5 373 milj. USD20242025: 5 935 milj. USD20255 935
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Inpatient rehabilitation hospital services90 %

Specialized inpatient care and therapy for patients recovering from major injury or illness.

Non-patient care revenue10 %

State directed and supplemental payments plus management and administrative fees.

Tuotteet

Raportoitu · osuus liikevaihdosta
97,0%FY2025100 %
  • Inpatient97,0 %
  • Other3,0 %

Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

The company serves patients referred after acute-care hospitalization who need intensive rehabilitation before returning home or to a lower level of care. Its economic buyers are primarily Medicare, Medicare Advantage, Medicaid, commercial payors, and other third-party payors that reimburse the care, while referrals come from hospitals, physicians, and case managers. Growth depends on maintaining access to these referral sources and demonstrating better outcomes and cost-effective care.

Patient referrals from acute-care hospitals

Hospitals discharge patients needing intensive rehab; this is the main source of admissions and is strategically critical.

Medicare and Medicare Advantage beneficiaries

Older and medically complex patients whose reimbursement drives a large share of operating revenue.

Commercial and managed care payors

Insured patients whose contracts and utilization rules affect pricing and admission flow.

Medicaid patients and state programs

Patients covered by Medicaid, including supplemental payment programs that support revenue.

Physicians, case managers, and referral networks

Influence patient placement decisions and determine access to admissions in local markets.

Strategia

The company is expanding capacity through de novo hospitals, joint ventures, remote and satellite hospitals, and bed additions while preserving a flexible balance sheet. Management is positioning the business to benefit from coordinated care and payment models by emphasizing high-quality outcomes, cost-effective care, and strong referral relationships. Real estate ownership and limited near-term debt maturities support continued growth and adaptation to reimbursement changes.

De novo hospital expansion and bed additionsKeskipitkä aikaväli

Adds capacity in markets with strong demand and supports long-term volume growth.

Referral-source relationship managementLyhyt aikaväli

Admissions depend heavily on acute-care hospital and physician referrals.

Operational quality and cost efficiencyKeskipitkä aikaväli

Better outcomes and lower cost per episode strengthen payer and referral acceptance.

Balance sheet flexibilityLyhyt aikaväli

Supports growth and cushions reimbursement or regulatory volatility.

Maantiede

Encompass Health operates across 39 states and Puerto Rico, with especially heavy concentration in Florida and Texas. Its footprint is built around local referral relationships and certificate-of-need markets, so geography directly affects admissions, competitive intensity, and expansion opportunities. The company continues to add beds and open de novo hospitals in growth markets such as Florida, Texas, Pennsylvania, Arizona, and the Southeast.

Riskit

The biggest risk is reimbursement pressure, especially from Medicare, Medicaid, and managed care, because the company’s revenue depends on regulated payment rates and complex billing rules. It also faces referral concentration risk since most admissions come from acute-care hospitals, plus execution risk from acquisitions, joint ventures, and new hospital development. As a healthcare operator, it is exposed to compliance, cybersecurity, and Medicare participation risks that can disrupt operations or trigger penalties.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Reimbursement reductions or rule changes1Referral-source concentration2Regulatory and Medicare compliance3Competitive pressure in local markets4Acquisition and joint venture execution5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Reimbursement reductions or rule changesVaikutus: KorkeaTodennäköisyys: Kohtalainen

    A large share of revenue comes from Medicare and other regulated payors.

    KohdistuuMedicareMedicaidManaged care
  2. Referral-source concentrationVaikutus: KorkeaTodennäköisyys: Kohtalainen

    About 92% of admissions come from acute-care hospitals, so referral shifts can quickly affect volumes.

    Kohdistuu: Acute-care hospital networks and physician relationships

  3. Regulatory and Medicare complianceVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Failure to meet conditions of participation or anti-kickback rules could disrupt operations.

    Kohdistuu: Hospital-level compliance and billing practices

  4. Competitive pressure in local marketsVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Other post-acute providers and acute-care systems can expand rehab offerings and compete for patients.

    Kohdistuu: Local market share and admissions

  5. Acquisition and joint venture executionVaikutus: KeskitasoTodennäköisyys: Matala

    Growth strategy relies on transactions that can face approvals, integration issues, and hidden liabilities.

    KohdistuuDe novo projectsJVsAcquisitions

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition estimates

Net operating revenue is recorded using estimated transaction prices and allowances, so small assumption changes can move revenue.

Vaikutus: Affects reported revenue, receivables, and margin timing

Medicare and Medicaid reimbursement settlements

Government program rules and reviews can create retroactive adjustments and volatility.

Vaikutus: Can change revenue and other income across periods

Supplemental payments and provider taxes

State-directed payments are included in other revenue while related provider taxes hit expenses.

Vaikutus: Affects operating revenue mix and expense comparability

Asset depreciation and impairment

Hospital real estate and equipment are capital intensive, and underperforming assets may be impaired.

Vaikutus: Influences operating profit and non-cash charges

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 24.9.2026